Inpharma Weekly

, Volume 1283, Issue 1, pp 7–7

STI-571 active and well tolerated in CML and ALL

Clinical study

DOI: 10.2165/00128413-200112830-00013

Cite this article as:
Inpharma Wkly. (2001) 1283: 7. doi:10.2165/00128413-200112830-00013

Copyright information

© Adis International Ltd 2001